NO971934L - Flourinerte vitamin D3 -analoger - Google Patents

Flourinerte vitamin D3 -analoger

Info

Publication number
NO971934L
NO971934L NO971934A NO971934A NO971934L NO 971934 L NO971934 L NO 971934L NO 971934 A NO971934 A NO 971934A NO 971934 A NO971934 A NO 971934A NO 971934 L NO971934 L NO 971934L
Authority
NO
Norway
Prior art keywords
analogues
fluorinated vitamin
disorders
hydroxyl
hydrogen
Prior art date
Application number
NO971934A
Other languages
English (en)
Other versions
NO971934D0 (no
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO971934D0 publication Critical patent/NO971934D0/no
Publication of NO971934L publication Critical patent/NO971934L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Forbindelse med formel I HO^ hvor R er hydrogen, fluor eller hydroksyl, og X er =CH2 eller når R er hydroksyl, er X hydrogen eller =CH2 er anvendelig ved behandling av hyperprolifera- tive lidelser, neoplastiske lidelser og talgkjertel- lidelser.
NO971934A 1996-05-23 1997-04-25 Flourinerte vitamin D3 -analoger NO971934L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1818796P 1996-05-23 1996-05-23

Publications (2)

Publication Number Publication Date
NO971934D0 NO971934D0 (no) 1997-04-25
NO971934L true NO971934L (no) 1997-11-24

Family

ID=21786696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971934A NO971934L (no) 1996-05-23 1997-04-25 Flourinerte vitamin D3 -analoger

Country Status (30)

Country Link
US (1) US5888994A (no)
EP (1) EP0808831B1 (no)
JP (1) JP2858571B2 (no)
KR (1) KR100237523B1 (no)
CN (1) CN1081184C (no)
AR (1) AR007240A1 (no)
AT (1) ATE195514T1 (no)
AU (1) AU720098B2 (no)
BR (1) BR9703373A (no)
CA (1) CA2204478C (no)
CO (1) CO4840512A1 (no)
CZ (1) CZ157997A3 (no)
DE (1) DE69702812T2 (no)
DK (1) DK0808831T3 (no)
ES (1) ES2150719T3 (no)
GR (1) GR3034832T3 (no)
HR (1) HRP970274A2 (no)
HU (1) HUP9700927A3 (no)
IL (1) IL120842A0 (no)
MA (1) MA24345A1 (no)
NO (1) NO971934L (no)
NZ (1) NZ314838A (no)
PL (1) PL320131A1 (no)
PT (1) PT808831E (no)
SG (1) SG50831A1 (no)
TR (1) TR199700418A3 (no)
TW (1) TW374762B (no)
UY (1) UY24563A1 (no)
YU (1) YU19997A (no)
ZA (1) ZA974334B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
DE69832699T2 (de) 1997-05-16 2006-08-24 Woman & Infants Hospital Zyklische äther vitamin d3 verbindungen, 1alfa(oh) 3-epi-vitamin d3 verbindungen und deren verwendungen
US6017908A (en) * 1997-05-16 2000-01-25 Women And Infants Hospital 3-EPI vitamin D2 compounds and uses thereof
JP4219553B2 (ja) * 1997-09-08 2009-02-04 エフ．ホフマン−ラ ロシュ アーゲー １，３−ジヒドロキシ−２０，２０−ジアルキル−ビタミンｄ３類似体
WO2000051554A2 (en) * 1999-03-05 2000-09-08 Johns Hopkins University Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
CA2586679A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
PT3095447T (pt) 2006-02-03 2022-01-24 Opko Renal Llc Tratamento da insuficiência e deficiência de vitamina d com 25-hidroxivitamina d2 e 25-hidroxivitamina d3
DK2037936T3 (da) 2006-06-21 2014-09-22 Opko Renal Llc Fremgangsmåde til behandling og forebyggelse af sekundær hyperparathyroidisme
CA2683628C (en) 2007-04-25 2018-03-06 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
KR101691876B1 (ko) 2007-04-25 2017-01-02 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
US8754067B2 (en) 2010-11-12 2014-06-17 Wisconsin Alumni Research Foundation 22-haloacetoxy-homopregnacalciferol analogs and their uses
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
KR20180123100A (ko) 2016-03-28 2018-11-14 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039671A (en) * 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
DK0580968T3 (da) * 1992-05-20 1996-10-14 Hoffmann La Roche Fluorerede analoger af vitamin D3
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
TW267161B (no) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger

Also Published As

Publication number Publication date
CA2204478A1 (en) 1997-11-23
ATE195514T1 (de) 2000-09-15
HUP9700927A3 (en) 1999-07-28
AR007240A1 (es) 1999-10-27
TR199700418A2 (xx) 1997-12-21
TW374762B (en) 1999-11-21
KR970074763A (ko) 1997-12-10
DE69702812T2 (de) 2001-01-25
CO4840512A1 (es) 1999-09-27
PL320131A1 (en) 1997-11-24
JP2858571B2 (ja) 1999-02-17
CN1169425A (zh) 1998-01-07
KR100237523B1 (ko) 2000-01-15
EP0808831A2 (en) 1997-11-26
US5888994A (en) 1999-03-30
IL120842A0 (en) 1997-09-30
PT808831E (pt) 2000-12-29
GR3034832T3 (en) 2001-02-28
AU720098B2 (en) 2000-05-25
SG50831A1 (en) 1998-07-20
NO971934D0 (no) 1997-04-25
YU19997A (sh) 1999-07-28
UY24563A1 (es) 2000-12-29
MX9703776A (es) 1998-06-30
ES2150719T3 (es) 2000-12-01
EP0808831A3 (en) 1999-02-03
HRP970274A2 (en) 1998-04-30
NZ314838A (en) 1998-01-26
JPH1045712A (ja) 1998-02-17
CN1081184C (zh) 2002-03-20
ZA974334B (en) 1997-11-24
MA24345A1 (fr) 1998-07-01
DK0808831T3 (da) 2001-01-02
BR9703373A (pt) 1998-09-15
HUP9700927A2 (hu) 1998-01-28
EP0808831B1 (en) 2000-08-16
CZ157997A3 (en) 1997-12-17
TR199700418A3 (tr) 1997-12-21
DE69702812D1 (de) 2000-09-21
AU2357297A (en) 1997-11-27
HU9700927D0 (en) 1997-07-28
CA2204478C (en) 2006-11-21

Similar Documents

Publication Publication Date Title
NO972304L (no) Vitamin D3-analoger
GB2102287B (en) Use of aromatase-inhibitors with antiandrogens for treatment of prostatic hyperplasia.
HU9301361D0 (en) Method for producing 4-aryl-piperazines and 4-aryl-piperidines
TW374762B (en) Fluorinated vitamin D3 analogs
ZA899251B (en) Hypocholesterolemic and antiatherosclerotic uses of bis(3,5-ditertiary-butyl-4-hydroxyphenylthio)methane
ZA9710292B (en) Atherosclerosis treatment
NO894201D0 (no) Badetilsetningsmiddel.
ID24308A (id) Plasma darah yang dapat diaplikasikan secara universal
ATE141914T1 (de) Fluorierte analoge vitamins d3
NO934197L (no) Vitamin D-3-analoger
IN167848B (no)
CS472690A3 (en) Combination preparation with antithrombotic effect
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
DK0520372T3 (da) Inositol-phosphat-analoger som calciumantagonistiske stoffer
ECSP972130A (es) Analogos de vitamina d3 - fluorinados
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
MX9708190A (es) Metodo para tratar dioxido de cloro.
NO995132D0 (no) Fremgangsmåte for reduksjon av fibrinogen
GB9125057D0 (en) Treatment of gas
ATE174965T1 (de) Verfahren zur herstellung von halogenierten hydroxyphenylessigsäuren
KR960700729A (ko) 26,26,26,27,27,27-헥사플루오로-1 알파, 25-디히드록시콜레칼시페롤의 칼슘 대사 장애의 치료 용도(Use of 26,26,26,27,27,27-Hexafluoro-1alpha, 25-Dihydroxycholecalciferol for the treatment of Calcium Metabolism Disorders)
MD259C2 (ro) Metodă de tratament al maladiei ulceroase a duodenului, complicată cu stenoză piloroduodenală
MX9207565A (es) Hidroxilacion.
IT1244888B (it) Procedimento per la sintesi di composti aromatici fluorurati
GR960100116A (el) Μεθοδος παρασκευης 1-κυκλοπροπυλο-6-φλουορο-1,4-διυδρο-7-[(1s,4s)-5-μεθυλο-2,5-διαζαβικυκλο[2.2.1]-επτ-2-υλο] -4-οξο-3-κουινολινοκαρβοξυλικο οξυ και αλατα αυτων.